Eintrag weiter verarbeiten

Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Journal of Clinical Oncology
Personen und Körperschaften: Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk
In: Journal of Clinical Oncology, 32, 2014, 15_suppl, S. 9031-9031
Format: E-Article
Sprache: Englisch
veröffentlicht:
American Society of Clinical Oncology (ASCO)
Schlagwörter:
author_facet Zimmer, Lisa
Eigentler, Thomas K.
Vaubel, Julia-Marianne
Mohr, Peter
Jradi, Zeinab
Kiecker, Felix
Utikal, Jochen
Berking, Carola
Kämpgen, Eckhart
Hauschild, Axel
Dippel, Edgar
Rompel, Rainer
Fluck, Michael
Stadler, Rudolf
Herbst, Rudolf
Terheyden, Patrick
Garbe, Claus
Loquai, Carmen
Schadendorf, Dirk
Zimmer, Lisa
Eigentler, Thomas K.
Vaubel, Julia-Marianne
Mohr, Peter
Jradi, Zeinab
Kiecker, Felix
Utikal, Jochen
Berking, Carola
Kämpgen, Eckhart
Hauschild, Axel
Dippel, Edgar
Rompel, Rainer
Fluck, Michael
Stadler, Rudolf
Herbst, Rudolf
Terheyden, Patrick
Garbe, Claus
Loquai, Carmen
Schadendorf, Dirk
author Zimmer, Lisa
Eigentler, Thomas K.
Vaubel, Julia-Marianne
Mohr, Peter
Jradi, Zeinab
Kiecker, Felix
Utikal, Jochen
Berking, Carola
Kämpgen, Eckhart
Hauschild, Axel
Dippel, Edgar
Rompel, Rainer
Fluck, Michael
Stadler, Rudolf
Herbst, Rudolf
Terheyden, Patrick
Garbe, Claus
Loquai, Carmen
Schadendorf, Dirk
spellingShingle Zimmer, Lisa
Eigentler, Thomas K.
Vaubel, Julia-Marianne
Mohr, Peter
Jradi, Zeinab
Kiecker, Felix
Utikal, Jochen
Berking, Carola
Kämpgen, Eckhart
Hauschild, Axel
Dippel, Edgar
Rompel, Rainer
Fluck, Michael
Stadler, Rudolf
Herbst, Rudolf
Terheyden, Patrick
Garbe, Claus
Loquai, Carmen
Schadendorf, Dirk
Journal of Clinical Oncology
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
Cancer Research
Oncology
author_sort zimmer, lisa
spelling Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031 Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2014.32.15_suppl.9031
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC45MDMx
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC45MDMx
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint American Society of Clinical Oncology (ASCO), 2014
imprint_str_mv American Society of Clinical Oncology (ASCO), 2014
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str zimmer2014openlabelmulticentersinglearmphaseiistudydecogtrialtofurtherevaluatetheefficacyandsafetyofipilimumabinpatientswithcutaneousmelanomaandraresubgroups
publishDateSort 2014
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_unstemmed Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_full Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_fullStr Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_full_unstemmed Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_short Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_sort open-label, multicenter, single-arm phase ii study (decog-trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031
publishDate 2014
physical 9031-9031
description
container_issue 15_suppl
container_start_page 9031
container_title Journal of Clinical Oncology
container_volume 32
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792320472386371588
geogr_code not assigned
last_indexed 2024-03-01T10:46:40.651Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Open-label%2C+multicenter%2C+single-arm+phase+II+study+%28DeCOG-Trial%29+to+further+evaluate+the+efficacy+and+safety+of+ipilimumab+in+patients+with+cutaneous+melanoma+and+rare+subgroups.&rft.date=2014-05-20&genre=article&issn=1527-7755&volume=32&issue=15_suppl&spage=9031&epage=9031&pages=9031-9031&jtitle=Journal+of+Clinical+Oncology&atitle=Open-label%2C+multicenter%2C+single-arm+phase+II+study+%28DeCOG-Trial%29+to+further+evaluate+the+efficacy+and+safety+of+ipilimumab+in+patients+with+cutaneous+melanoma+and+rare+subgroups.&aulast=Schadendorf&aufirst=Dirk&rft_id=info%3Adoi%2F10.1200%2Fjco.2014.32.15_suppl.9031&rft.language%5B0%5D=eng
SOLR
_version_ 1792320472386371588
author Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk
author_facet Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk, Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk
author_sort zimmer, lisa
container_issue 15_suppl
container_start_page 9031
container_title Journal of Clinical Oncology
container_volume 32
description
doi_str_mv 10.1200/jco.2014.32.15_suppl.9031
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC45MDMx
imprint American Society of Clinical Oncology (ASCO), 2014
imprint_str_mv American Society of Clinical Oncology (ASCO), 2014
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T10:46:40.651Z
match_str zimmer2014openlabelmulticentersinglearmphaseiistudydecogtrialtofurtherevaluatetheefficacyandsafetyofipilimumabinpatientswithcutaneousmelanomaandraresubgroups
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 9031-9031
publishDate 2014
publishDateSort 2014
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031 Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. Journal of Clinical Oncology
spellingShingle Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk, Journal of Clinical Oncology, Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups., Cancer Research, Oncology
title Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_full Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_fullStr Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_full_unstemmed Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_short Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_sort open-label, multicenter, single-arm phase ii study (decog-trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
title_unstemmed Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031